TrialHaematologica2018

Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia.

Bruno C Medeiros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.